Michèle Allouche Selected Research

p80(NPM-ALK) protein

7/2007	ALK is a novel dependence receptor: potential implications in development and cancer.
8/2006	Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michèle Allouche Research Topics

Disease

5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2019 - 02/2004
4	Neoplasms (Cancer) 02/2019 - 08/2004
2	Lymphoma (Lymphomas) 07/2007 - 02/2004
1	Breast Neoplasms (Breast Cancer) 02/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2019
1	Neuroblastoma 02/2019
1	Keratoconus 08/2011
1	Melanoma (Melanoma, Malignant) 08/2011
1	Genetic Translocation (Chromosomal Translocation) 02/2004
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2002

Drug/Important Bio-Agent (IBA)

5	Anaplastic Lymphoma KinaseIBA 02/2019 - 02/2004
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2019 - 08/2006
2	Biological ProductsIBA 08/2011 - 07/2007
2	Proteins (Proteins, Gene)FDA Link 12/2008 - 07/2007
2	p80(NPM-ALK) proteinIBA 07/2007 - 08/2006
2	Pyridinolcarbamate (P23)IBA 08/2004 - 02/2004
1	Phosphotransferases (Kinase)IBA 02/2019
1	Peptides (Polypeptides)IBA 02/2019
1	Tyrosine Kinase InhibitorsIBA 02/2019
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2011
1	RNA (Ribonucleic Acid)IBA 08/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2007
1	Tyrosine (L-Tyrosine)FDA Link 08/2004
1	NucleophosminIBA 08/2004
1	Monoclonal AntibodiesIBA 01/2002

Therapy/Procedure

2	Therapeutics 02/2019 - 07/2007